Design, Synthesis, and In Vitro and In Silico Biological Exploration of Novel Pyridine-Embedded 1,3,4-Oxadiazole Hybrids as Potential Antimicrobial Agents
Antibiotic resistance represents a significant public health challenge in the current century. The β-lactam antibiotics, together with carbapenems, are inactivated by zinc-dependent bacterial enzymes called metallo-β-lactamases (MBLs). Presently there are no clinically permitted MBL inhibitors, and...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-01-01
|
| Series: | Journal of Chemistry |
| Online Access: | http://dx.doi.org/10.1155/joch/4427650 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Antibiotic resistance represents a significant public health challenge in the current century. The β-lactam antibiotics, together with carbapenems, are inactivated by zinc-dependent bacterial enzymes called metallo-β-lactamases (MBLs). Presently there are no clinically permitted MBL inhibitors, and to produce such drugs, it is indispensable to comprehend their inhibitory action. We investigated an efficient synthesis of pyridine-embedded 1,3,4-oxadiazole hybrids (3a-c) and their antimicrobial activity against different microbial strains. The compounds were characterized by spectral techniques (viz., IR, NMR, and mass). The in vitro antibacterial and antifungal activity was also performed; the compounds (3a-c) displayed excellent antimicrobial activity. The in silico docking studies were evaluated with proteins New Delhi Metallo-Beta-lactamase-1 (NDM-1) and Mycobacterium tuberculosis enoyl reductase (INHA). All the compounds demonstrated a significant binding affinity for the docked proteins. Additionally, molecular dynamics were disclosed for compounds (4a-c). |
|---|---|
| ISSN: | 2090-9071 |